Azithromycin Market

Global Azithromycin Market Size, Share & Trends Analysis Report, By Product (Oral, Injectable, and Ophthalmic), By Application (Bacterial Infections, Mycobacterium Avium Complex (MAC) Infection, and Others), Forecast (2021-2027)
    Update Available - Forecast 2024-2030   

Published: Jul 2023 | Report Code: OMR2025336 | Category : Pharmaceuticals | Delivery Format: /

The global azithromycin market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). The major factor that is driving the market growth includes the increasing prevalence of bacterial infection. Azithromycin is a class of drugs, belongs to anti-bacterial antibiotics. It is an antibiotic that supports the treatment of bacterial infections. It is commonly sold under the brand names Zithromax and Zmax. A doctor may prescribe azithromycin to treat mild-to-moderate infections of the lungs, sinuses, skin, and other body parts. It can resist harmful bacteria from growing and is able to fight a wide range of bacteria, including many in the streptococcus family.

Azithromycin is among the world’s best-selling antibiotics. It is proved to be extremely efficient and capable of remaining in the body tissue longer than another similar alternative. Companies are investing and investigating significantly in the azithromycin market for a new treatment, opening the way to new markets. Increasing prevalence of bacterial infections, rising focus on expanding application scope of azithromycin for different indications, and increasing availability of azithromycin tablets as generic and brand-name drugs are some factors, that are expected to boost the market growth. Moreover, rising investment and funding to accelerate research activities in the pharmaceutical sector and an increasing number of product approvals from regulatory bodies are other key factors expected to contribute to market growth during the forecast period.

Market Coverage

The market number available for – 2020-2027

Base year- 2020

Forecast period- 2021-2027

Segment Covered- 

o By Product

o By Application 

Regions covered-

o North America

o Europe

o Asia-Pacific

o Rest of the World

Competitive Landscape: Pfizer Inc., Mylan N.V., and Teva Pharmaceutical Industries Ltd., among others.

Key questions addressed by the report

What is the market growth rate?

Which segment and region dominate the market in the base year?

Which segment and region will project the fastest growth in the market?

How has COVID-19 impacted the market?

o Deviation from the pre-COVID-19 forecast

o Most affected region and segment

Who is the leader in the market?

How are players addressing challenges to sustain growth?

Where is the investment opportunity?

Global Azithromycin Market Report Segmentation

By Product

Oral

Injectable

Ophthalmic

By Application

Bacterial Infections

Mycobacterium Avium Complex (MAC) Infection

Others

Global Azithromycin Market by Region

North America

  • United States
  • Canada

Europe

  • UK
  • Germany
  • Italy
  • Spain
  • France
  • Rest of Europe 

Asia-Pacific

  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific